Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · Real-Time Price · USD

1.760

-0.050 (-2.76%)

At close: Aug 28, 2026, 4:00 PM EDT

1.750

-0.010 (-0.57%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Clearmind Medicine Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	11.42	3.92	6.57	5.43	0.13	3.71
Short-Term Investments	2.18	1.66	0.29	0.09	0.19	-
Cash & Short-Term Investments	13.59	5.59	6.86	5.51	0.32	3.71
Cash Growth	192.32%	-18.62%	24.47%	1609.58%	-91.31%	1396.58%
Other Receivables	0.55	0.32	0.18	0.24	0.1	0.13
Receivables	0.55	0.32	0.18	0.24	0.1	0.13
Prepaid Expenses	0.18	0.04	0.04	0.04	0.01	0.13
Total Current Assets	14.32	5.95	7.09	5.79	0.43	3.97
Property, Plant & Equipment	0.09	0.02	0.05	0	0.05	0.02
Other Intangible Assets	0.09	0.1	0.11	0.12	0.13	0.16
Long-Term Deferred Charges	-	-	-	-	0.2	-
Other Long-Term Assets	0.02	0.02	0.01	0.04	0.01	0.02
Total Assets	14.52	6.08	7.26	5.95	0.83	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Accounts Payable	0.71	0.68	0.53	0.62	1.4	0.28
Accrued Expenses	0.1	0.06	0.05	0.04	0.21	0.01
Current Portion of Long-Term Debt	-	1.76	-	-	-	-
Current Portion of Leases	0.04	0.02	0.04	-	0.04	-
Other Current Liabilities	2.14	2.37	3.52	4.31	0.29	-
Total Current Liabilities	2.99	4.89	4.13	4.97	1.93	0.29
Long-Term Leases	0.04	-	0.02	-	-	-
Total Liabilities	3.03	4.89	4.15	4.97	1.93	0.29

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Common Stock	42.66	26.4	24.17	17.13	6.71	6.38
Retained Earnings	-33.78	-27.88	-24.02	-18.77	-10.15	-3.58
Comprehensive Income & Other	2.61	2.67	2.96	2.62	2.33	1.08
Shareholders' Equity	11.49	1.19	3.11	0.98	-1.11	3.87
Total Liabilities & Equity	14.52	6.08	7.26	5.95	0.83	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Total Debt	0.09	1.78	0.05	-	0.04	-
Net Cash (Debt)	13.51	3.81	6.81	5.51	0.28	3.71
Net Cash Growth	192.74%	-44.10%	23.51%	1840.56%	-92.34%	1396.58%
Net Cash Per Share	122.18	299.52	-	-	-	-
Filing Date Shares Outstanding	1.49	0.02	0.01	-	-	-
Total Common Shares Outstanding	1.02	0.02	0.01	-	-	-
Working Capital	11.33	1.06	2.96	0.82	-1.5	3.68
Book Value Per Share	11.28	75.44	291.43	-	-	-
Tangible Book Value	11.4	1.1	3	0.86	-1.24	3.71
Tangible Book Value Per Share	11.19	69.28	281.27	-	-	-
Machinery	-	-	-	-	-	0.02

SEC Filings: 10-K · 10-Q